New York S 6925: Relates to capping cost sharing for antiviral COVID-19 therapeutics

Status: REFERRED TO INSURANCE (as of 2025-03-27)

State: New York · Session: 2025-2026 · Bill: S 6925

Sponsors: Brad Hoylman-Sigal

View New York S 6925 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.